Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Number of holders
-
259
-
Total 13F shares, excl. options
-
46,852,382
-
Shares change
-
-847,619
-
Total reported value, excl. options
-
$2,975,069,325
-
Value change
-
-$42,975,705
-
Put/Call ratio
-
66%
-
Number of buys
-
153
-
Number of sells
-
-95
-
Price
-
$63.50
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2019
300 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q1 2019.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46,852,382 shares
of 67,604,359 outstanding shares and own 69% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,910,957 shares), BlackRock Inc. (3,971,575 shares), FRED ALGER MANAGEMENT INC (2,641,882 shares), LORD, ABBETT & CO. LLC (1,759,958 shares), FEDERATED INVESTORS INC /PA/ (1,601,077 shares), WELLINGTON MANAGEMENT GROUP LLP (1,436,299 shares), EAGLE ASSET MANAGEMENT INC (1,307,033 shares), TimesSquare Capital Management, LLC (1,245,515 shares), STATE STREET CORP (1,236,871 shares), and TWO SIGMA ADVISERS, LP (927,572 shares).
This table shows the top 259 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.